Kamada Ltd

KMDA

Company Profile

  • Business description

    Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

  • Contact

    2 Holzman Street
    P.O. Box 4081
    Science Park
    Rehovot7670402
    ISR

    T: +972 89406472

    E: [email protected]

    https://www.kamada.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    374

Stocks News & Analysis

stocks

ASX listed tariff play

Trump’s focus on US steel production may benefit this firm.
stocks

Ask the analyst: How reliant are Guzman shares on international growth?

A year on from Guzman’s IPO, I catch up with Johannes Faul to explore what is baked into GYG’s valuation.
stocks

Nvidia: Back in business in China; Raising fair value estimate

Nvidia is poised to become more dominant than ever as it is allowed to sell its key H20 GPUs in China.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,863.7047.300.54%
CAC 407,722.0944.12-0.57%
DAX 4024,009.3850.91-0.21%
Dow JONES (US)44,254.78231.490.53%
FTSE 1008,926.5511.77-0.13%
HKSE24,514.443.32-0.01%
NASDAQ20,730.4952.690.25%
Nikkei 22539,728.4865.080.16%
NZX 50 Index12,912.72158.131.24%
S&P 5006,263.7019.940.32%
S&P/ASX 2008,612.3050.500.59%
SSE Composite Index3,506.943.160.09%

Market Movers